Chadi Nabhan/chadinabhan.com
Jul 28, 2025, 15:12
Chadi Nabhan: ODAC voted “NO” on approving Blenrep 4 R/R Myeloma
Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:
“Recently, ODAC voted “NO” on approving Blenrep 4 R/R Myeloma. In a back-to-back HUExpress, I get Vincent Rajkumar thoughts on that decision and I also host Greg to give us “behind the scenes” on what happened that day at ODAC.
Two must watch EPs coming your way this week.”
Proceed to the video attached to the post.
More posts featuring Chadi Nabhan on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 18, 2025, 15:02
Aug 18, 2025, 14:54
Aug 18, 2025, 14:54
Aug 18, 2025, 14:47